Rachel Vaknin

CIK: 0001923217

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MBOT

Microbot Medical Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

MBOT
Microbot Medical Inc.
Feb 18, 2026
Award(A)
Stock Option (Right to Buy)
Direct
105K shares-
MBOT
Microbot Medical Inc.
Feb 5, 2025
Award(A)
Stock Option (Right to Buy)
Direct
48.1K shares-
MBOT
Microbot Medical Inc.
Feb 26, 2024
Award(A)
Stock Option (Right to Buy)
Direct
4.4K shares-

		Type	Shares	Price		Ownership
Feb 18, 2026	MBOT Microbot Medical Inc.	Award(A) Stock Option (Right to Buy)	105,000	-	-	Direct
Feb 5, 2025	MBOT Microbot Medical Inc.	Award(A) Stock Option (Right to Buy)	48,125	-	-	Direct
Feb 26, 2024	MBOT Microbot Medical Inc.	Award(A) Stock Option (Right to Buy)	4,375	-	-	Direct

1-3 of 3 transactions

About Vaknin Rachel

Vaknin Rachel (SEC CIK 0001923217) files insider reports with the SEC as Chief Financial Officer of Microbot Medical Inc. (MBOT).

Signal8 holds 2 ownership filings by Vaknin Rachel, all Form 4s, filed between Feb 7, 2025 and Feb 20, 2026. Those filings report 3 transactions, from Feb 26, 2024 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vaknin Rachel's filings is in HINGHAM, MA.

Recent filings by Vaknin Rachel

Feb 18, 2026: Grant or award of MBOT derivative securities (Form 4, code A).
Feb 5, 2025: Grant or award of MBOT derivative securities (Form 4, code A).
Feb 26, 2024: Grant or award of MBOT derivative securities (Form 4, code A).

Other insiders filing for Microbot Medical Inc. (MBOT)

How to read Form 4 transaction codes